Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
162M
-
Number of holders
-
267
-
Total 13F shares, excl. options
-
171M
-
Shares change
-
+5.99M
-
Total reported value, excl. options
-
$1.49B
-
Value change
-
+$22.5M
-
Put/Call ratio
-
0.08
-
Number of buys
-
133
-
Number of sells
-
-125
-
Price
-
$8.71
Significant Holders of IRONWOOD PHARMACEUTICALS INC - Class A Common Stock (IRWD) as of Q1 2024
327 filings reported holding IRWD - IRONWOOD PHARMACEUTICALS INC - Class A Common Stock as of Q1 2024.
IRONWOOD PHARMACEUTICALS INC - Class A Common Stock (IRWD) has 267 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 171M shares
.
Largest 10 shareholders include BlackRock Inc. (24.2M shares), VANGUARD GROUP INC (19.5M shares), Sarissa Capital Management LP (16.4M shares), STATE STREET CORP (13.9M shares), Pacer Advisors, Inc. (7.21M shares), RENAISSANCE TECHNOLOGIES LLC (7.1M shares), LSV ASSET MANAGEMENT (6.15M shares), ARMISTICE CAPITAL, LLC (5.4M shares), JACOBS LEVY EQUITY MANAGEMENT, INC (4.24M shares), and BRAIDWELL LP (3.49M shares).
This table shows the top 267 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.